Related Experiment Video
Updated: Apr 26, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression
Hasaya Dokduang1, Anchalee Techasen, Nisana Namwat
1Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand; Liver Fluke and Cholangiocarcinoma Research Center, Khon Kaen University, Khon Kaen, Thailand.
Background:
We investigated the aberrant expression of the STAT family in humans and liver fluke (Opisthorchis viverrini, Ov)-induced hamster cholangiocarcinoma (CCA) tissues.
Methods:
The expression and phosphorylation of STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and STAT6 in human hamster CCA tissues were immunohistochemistry-profiled. Localizations of STAT5 in macrophages and lipopolysaccharide (LPS)-induced macrophage-conditioned media mediated STAT3 activation in CCA cells were demonstrated.
Results:
The expressions of STAT 1-4 and 6 were detected in the cytoplasm of hyperplastic bile ducts and tumor cells, whereas STAT5a and STAT5b were observed in macrophages and connective tissues surrounding tumor, respectively. The expressions of STAT3 and STAT5b were significantly observed in tumors with a poorer histological differentiation. STAT3 expression was significantly associated with shorter survival of CCA patients and was predominately activated in CCA cell lines. In the CCA-hamsters, STATs expression was gradually increased along the carcinogenesis, especially at 30 days post-infection in which the inflammatory response was markedly observed, showing the correlation between the inflammation and STATs activation. Moreover, LPS-induced macrophage-conditioned media could mediate STAT3 activation in CCA cells.
Conclusions:
STAT3 is the major STAT, which plays roles in the inflammation that contributes to CCA carcinogenesis and progression and may serve as a marker for a poor prognosis of CCA.
Insights
Signal transducer and activator of transcription (STAT) 3 is key in liver fluke-induced cholangiocarcinoma (CCA) inflammation and progression. STAT3 activation correlates with poor prognosis in CCA patients, suggesting its potential as a prognostic marker.
Area of Science:
- Oncology
- Immunology
- Parasitology
Background:
- Investigated aberrant Signal Transducer and Activator of Transcription (STAT) family expression in human and Opisthorchis viverrini (Ov)-induced hamster cholangiocarcinoma (CCA).
- Examined STAT family members including STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6.
Purpose of the Study:
- To elucidate the role of STAT family members in CCA development and progression.
- To determine the association between STAT expression, inflammation, and patient prognosis.
Main Methods:
- Immunohistochemistry was used to profile STAT expression and phosphorylation in human and hamster CCA tissues.
- Investigated STAT5 localization in macrophages and STAT3 activation in CCA cells mediated by lipopolysaccharide (LPS)-induced macrophage-conditioned media.
Main Results:
- STAT1-4 and STAT6 were found in hyperplastic bile ducts and tumor cells; STAT5a and STAT5b were located in macrophages and connective tissues.
- STAT3 and STAT5b expression correlated with poorer histological differentiation and shorter patient survival.
- STATs expression increased during carcinogenesis in hamsters, particularly with marked inflammation at 30 days post-infection, linking inflammation to STAT activation.
Conclusions:
- STAT3 is the primary STAT involved in inflammation contributing to CCA carcinogenesis and progression.
- STAT3 activation is predominantly observed in CCA cell lines.
- STAT3 may serve as a valuable prognostic marker for poor outcomes in CCA patients.
More Related Videos
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation